ホーム > 市場調査レポート > 医療機器 > 医療機器のブランド設定:アイデンティティと所有資産価値の表明
カテゴリ
医療機器 (4760)
CT/MRI/X線 (172)
eヘルス (329)
カテーテル (240)
ディスポーザブル (77)
画像診断 (417)
核医学 (80)
眼科機器 (102)
歯科機器 (176)
心血管装置 (339)
整形外科 (341)
生体計測 (391)
創傷ケア (163)
体外診断装置 (557)
超音波 (55)
内視鏡 (160)
分子イメージング/造影剤 (28)
市場調査レポート

医療機器のブランド設定:アイデンティティと所有資産価値の表明

Medical Device Branding - Building Identity and Equity

発行 HBS Consulting
出版日 2004年01月 商品コード 17872
ページ情報 英文  
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年07月19日を持ちまして終了しました。

原文目次

This latest strategic publication from HBS Consulting "Medical Device Branding - Building Identity and Equity" provides:

  • An analysis of the benefits and advantages various branding strategies can offer.
  • The mechanisms and models that can be employed to create a strong brand for the medical device industry.
  • Case studies reviewing branding experiences of companies within the medical device and diagnostic sectors.
  • Strategies for building and leveraging brand value.

The report is an invaluable resource illustrating - as it does with regularity throughout - how not only the major medical device manufacturers but also middle-tier and smaller players manage their brand strategy to garner positive competitive advantage. Strategy review, "Medical Device Branding - Building Identity and Equity", will be of particular value to business development, marketing and top-line corporate personnel as well as to all involved in brand development and management.

Executive Summary

In the late 19th and early 20th Centuries a brand was frequently little more than the name that was attached to a product. The brand would normally consist of the name of the company and a descriptive name for the device. Such an example was the Rorstrand Inhaler introduced in 1874. This device was a ceramic vessel (made by Rorstrand) that could be filled with water and aromatic herbs and inhaled by people with chest disorders. Since this time the majority of medical device manufacturers have done little to take on board the lessons learnt from other consumer markets and many still label and brand their products with as little thought to the procedure as occurred over a hundred years previously.

In the 20th and 21st Centuries the idea of what a brand is has changed, and today the following statement is generally considered to be true:

In other markets the rewards of effective branding have been obvious for many years, with examples like the Coca Cola company whose value of $14 billion is almost entirely due to shrewd branding strategies leading the way. However, within the medical device industry the principal reason for not placing significant resources into branding campaigns has been that it was considered that the customers for medical devices were physicians and physicians were not thought to be affected by branding messages in the same way as other consumers were. In every way this view is now being challenged.    Firstly, the idea of who the customer is has been changing and those companies with foresight realise that, with regards to purchasing, physicians, technicians, nurses, budget holders and patients can all influence the purchasing decision. In turn, branding can influence all of these people.

Secondly, the view that the effect of branding messages on physicians differs from that placed on other consumers has been proven to be false. A more accurate assessment is that there are a number of other considerations that a physician has to bear in mind when making a purchase and as long as these are also fulfilled by the brand then the likelihood of making the sale is increased. Some medical device companies are therefore beginning to change their attitude towards branding as they realise that it can offer a number of rewards, not the least of which are:

  • Decreased administration costs.
  • Increased customer, investor and employee belief in the company.
  • Increased sales.
  • Increased company value.

Constructing, defining and communicating a company's brand message is not one simple procedure that can be applied across all situations. Instead the task comprises a number or set of related procedures.

Figure 1.1 illustrates the processes that are used within the medical device industry and which are discussed in more detail throughout the report.

Provisional Table of Contents

1. EXECUTIVE SUMMARY 5

1.1.1 Medical device branding and marketing strategies 9
1.2 Issues affecting the success of a global brand 11
1.3 Executing brand strategy to maximise ROI 12

2. INTRODUCTION 14

2.1 What are the origins of branding? 14
2.2 Branding history of the medical device sector 14
2.2.1 The continued evolution of branding and its components 14
2.3 The target audience 15

3. WHAT' S IN A NAME? 16

3.1 Market differentiation 16
3.1.1 Corporate differentiation ? making your company stand out from the crowd 16
3.1.2 Product differentiation 19
3.1.3 Differentiation conclusions 21
3.2 Customer awareness 22
3.2.1 Creating customer awareness 23
3.2.1 Brand equity 25
3.3 Corporate motivation 26
3.4 Product and corporate protection 27
3.5 Competition awareness (partnerships and alliances) 28

4. BRANDING ARCHITECTURE 30

4.1 What is branding architecture? 30
4.2 Branding architecture approaches 32
4.2.1 Product branding 32
4.2.3 Range branding 35
4.2.5 Shared branding 37
4.2.6 Endorsed branding 38
4.2.7 Corporate branding 38
4.2.8 Sub-brands 39
4.2.9 Brand architecture construction 39

5. MEDICAL DEVICE BRANDING AND MARKETING STRATEGIES 41

5.1 The Ansoff matrix 43
5.2 The Boston matrix 44
5.3 Directional policy matrix 47

6. ISSUES AFFECTING THE SUCCESS OF A GLOBAL BRAND 50

6.1.1 The brand logo 51
6.1.2 Brand inheritance 54
6.2 Promotion of a brand name 56
6.2.1 Brand promotion through clinical trials 56
6.2.2 Direct to patient promotion 58
6.3 Customer pressure and loyalty 60
6.3.1 Customer pressure 60
6.3.2 Customer loyalty 61
6.5 Pricing 68

7 POTENTIAL RETURNS OF BRANDING 70

7.1 Returns on investment 70
7.2 Impact of global branding on shareholder value 76

8. COMPANY EXAMPLES 82

8.1 Ethicon 82
8.1.1 Background 82
8.1.2 Finances 82
8.1.3 Branding structure. 84
8.1.4 Branding opinion 87
8.2 GE Medical Systems 89
8.2.1 Background 89
8.2.2 Finances 89
8.2.3 Branding structure. 90
8.2.4 Branding opinion 92
8.3 Guidant 92
8.3.1 Background 92
8.3.2 Finances 93
8.3.3 Branding structure. 94
8.3.4 Branding opinion 95
8.4 Medtronic 97
8.4.1 Background 97
8.4.2 Finances 97
8.4.3 Branding structure. 99
8.4.4 Branding opinion 101
8.5 Micro Medical 102
8.5.1 Background 102
8.5.2 Finances 102
8.5.3 Branding structure. 103
8.5.4 Branding opinion 103
8.6 Mallinckrodt imaging 105
8.6.1 Background 105
8.6.2 Finances 105
8.6.3 Branding structure. 107
8.6.4 Branding opinion 108
8.7 Roche Diagnostics 110
8.7.1 Background 110
8.7.2 Finances 110
8.7.3 Branding structure. 111
8.7.4 Branding opinion 113
Back to Top